InvestorsHub Logo
Followers 21
Posts 154
Boards Moderated 0
Alias Born 05/27/2008

Re: None

Sunday, 07/13/2014 8:35:36 PM

Sunday, July 13, 2014 8:35:36 PM

Post# of 403033
In anticipation of the completion of the current prurisol trial, which hopefully will be announced in the near future, I decided to google "abacavir+psoriasis."

Interestingly, one of the top hits (ehealthme.com) has a recent report regarding side effects that have been reported by patients treated with abacavir (typically HIV patients). Of note, only 0.2% of patients on abacavir reported psoriasis. However, the prevalence of psoriasis in the general population is significantly higher at 2-3%.

In regard to the above mentioned, I do not have access to how the data was collected and whether more patients taking abacavir have psoriasis but did not list it as a side effect - so caution is very much advised regarding speculation.

Nevertheless, this may be a hint that abacavir, or better yet, cellceutix's prurisol is efficacious in the treatment of psoriasis.

Thus, I am very much looking forward to a future proof of concept and/or phase 2/3 clinical trial prospectively looking at efficacy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News